Cassava Sciences | PTIE - Ordinary Share Capital


Cassava Sciences reported $48.31M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Amgen USD 541M 1000K Jun/2026
Biogen USD 146.7M 200K Sep/2025
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Cassava Sciences USD 48.31M 0 Mar/2026
Eisai JPY 282.46M 345K Jun/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Geron USD 640.9M 2.54M Mar/2026
J&J USD 2.41B 1.35M Mar/2026
Merck USD 2.47B 4.93M Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Novavax USD 162.58M 106K Dec/2025
Pfizer USD 5.7B 0 Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026